Global small molecule API market will reach $360.0 billion by 2032, growing by 7.0% annually over 2022-2032, driven by the increasing incidences of diseases, the development of high-potency small molecule APIs, patents expiry of the top-selling pharmaceuticals, the increasing technological developments in manufacturing sector, and a surging healthcare expenditure.
Highlighted with 119 tables and 84 figures, this 187-page report "Global Small Molecule API Market 2022-2032 by Source (Synthetic, Semi-synthetic, Natural), Product Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Region: Trend Forecast and Growth Opportunity" is based on comprehensive research of the entire global small molecule API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global small molecule API market in every aspect of the classification from perspectives of Source, Product Type, Therapeutic Area, Application, Manufacturer Type, and Region.
Based on Source, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Synthetic API
o Branded Synthetic API
o Generic Synthetic API
• Semi-synthetic API
• Natural Origin
Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Standard API
• High Potency API (HPAPI)
o Branded HPAPI
o Generic HPAPI
By Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Metabolic Diseases
• Other Therapeutic Areas
By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Clinical Use
• Commercial Use
By Manufacturer Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Pharmaceutical Companies
• CMOs
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)
For each region and country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and the breakdown of each national market by Product Type, Therapeutic Area, and Manufacturer Type over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Aurobindo Pharma Ltd.
Cambrex Corporation
Catalent Inc.
Dr. Reddy's Laboratories
GlaxoSmithKline plc
Lonza Group
Merck & Co., Inc.
Mylan N.V.
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Wuxi AppTec Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 26
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 28
2.2 Major Growth Drivers 32
2.3 Market Restraints and Challenges 36
2.4 Emerging Opportunities and Market Trends 39
2.5 Porter's Fiver Forces Analysis 43
3 Segmentation of Global Market by Source 47
3.1 Market Overview by Source 47
3.2 Synthetic API 49
3.2.1 Branded Synthetic API 50
3.2.2 Generic Synthetic API 51
3.3 Semi-synthetic API 52
3.4 Natural Origin 53
4 Segmentation of Global Market by Product Type 54
4.1 Market Overview by Product Type 54
4.2 Standard API 56
4.3 High Potency API (HPAPI) 57
4.3.1 Branded HPAPI 58
4.3.2 Generic HPAPI 59
5 Segmentation of Global Market by Therapeutic Area 60
5.1 Market Overview by Therapeutic Area 60
5.2 Infectious Diseases 62
5.3 Oncology 63
5.4 Ophthalmology 64
5.5 Cardiovascular Disorders 65
5.6 Central Nervous System 66
5.7 Respiratory Disorders 67
5.8 Metabolic Diseases 68
5.9 Other Therapeutic Areas 69
6 Segmentation of Global Market by Application 70
6.1 Market Overview by Application 70
6.2 Clinical Use 72
6.3 Commercial Use 73
7 Segmentation of Global Market by Manufacturer Type 74
7.1 Market Overview by Manufacturer Type 74
7.2 Pharmaceutical Companies 76
7.3 CMOs 78
8 Segmentation of Global Market by Region 80
8.1 Geographic Market Overview 2022-2032 80
8.2 North America Market 2022-2032 by Country 84
8.2.1 Overview of North America Market 84
8.2.2 U.S. 88
8.2.3 Canada 91
8.2.4 Mexico 93
8.3 European Market 2022-2032 by Country 95
8.3.1 Overview of European Market 95
8.3.2 Germany 99
8.3.3 U.K. 101
8.3.4 France 103
8.3.5 Spain 105
8.3.6 Italy 107
8.3.7 Russia 109
8.3.8 Rest of European Market 111
8.4 Asia-Pacific Market 2022-2032 by Country 113
8.4.1 Overview of Asia-Pacific Market 113
8.4.2 Japan 117
8.4.3 China 120
8.4.4 Australia 122
8.4.5 India 124
8.4.6 South Korea 126
8.4.7 Rest of APAC Region 128
8.5 South America Market 2022-2032 by Country 130
8.5.1 Argentina 133
8.5.2 Brazil 135
8.5.3 Chile 137
8.5.4 Rest of South America Market 139
8.6 MEA Market 2022-2032 by Country 140
8.6.1 UAE 143
8.6.2 Saudi Arabia 145
8.6.3 South Africa 147
8.6.4 Other National Markets 149
9 Competitive Landscape 150
9.1 Overview of Key Vendors 150
9.2 New Product Launch, Partnership, Investment, and M&A 153
9.3 Company Profiles 154
Aurobindo Pharma Ltd. 154
Cambrex Corporation 156
Catalent Inc. 157
Dr. Reddy's Laboratories 160
GlaxoSmithKline plc 163
Lonza Group 167
Merck & Co., Inc. 170
Mylan N.V. 172
Novartis AG 174
Pfizer Inc. 176
Sun Pharmaceutical Industries Ltd. 180
Teva Pharmaceutical Industries Ltd. 183
Wuxi AppTec Co., Ltd. 185
RELATED REPORTS 187
The Small Business Coaching Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Small Satellite Payload Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The Small Businesses Network Monitoring Tools Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive land...
The Small Business Coaching Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Small Businesses Inventory Management Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive...
The Small Businesses Barcode Inventory System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive land...
The Small Businesses Barcode Inventory Management Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, com...
Market Overview
The Asia Pacific Small Caliber Ammunition Market is set for robust growth from 2024 to 2034, driven by rising defense budgets, increasing geopolitical tensions, and expanding civilian use of firearms for sports and personal protection. The market is anticipated to reach ...
Market Overview
The Europe Small Caliber Ammunition Market is anticipated to witness substantial growth over the forecast period, driven by escalating demand from both military and commercial sectors. The market is projected to reach USD XX.XX billion by 2034, expanding at a CAGR of XX....
Market Overview
The North America Small Caliber Ammunition Market is poised for significant growth from 2024 to 2034, fueled by increasing defense expenditure, rising demand for personal safety, and expanding shooting sports activities. By 2034, the market is expected to reach a valuati...